# Unlearn.AI

its AI-generated digital twins are increasingly used to power synthetic control arms, and the company published a roadmap on causal inference and digital twins for the future of clinical trials in npj Digital Medicine in June 2026;…

Source: https://en.bioecon.ru/companies/unlearn-ai/
Updated: 2026-08-15

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $134.85 million total raised across multiple rounds, including a $50 million Series C in 2024 | https://www.businesswire.com/news/home/20240206806844/en/Unlearn-Raises-%2450-Million-Series-C-to-Optimize-Clinical-Research-With-AI-Powered-Digital-Twin-Technology |
| Headcount | Approximately 60-76 employees [medium confidence] | https://www.datanyze.com/companies/unlearnai/466385319 |
| Regulatory approval | European Medicines Agency (EMA) qualified their PROCOVA methodology for Phase 2 and 3 clinical trials; received positive feedback from U.S. FDA on the methodology | https://casrai.org/guides/digital-twins-clinical-trials, https://www.businesswire.com/news/home/20220928005391/en/European-Medicines-Agency-Qualifies-Unlearns-AI-powered-Method-for-Running-Smaller-Faster-Clinical-Trials, https://www.businesswire.com/news/home/20240206806844/en/Unlearn-Raises-%2450-Million-Series-C-to-Optimize-Clinical-Research-With-AI-Powered-Digital-Twin-Technology, https://www.unlearn.ai/digital-twins |
| Capacity | Technology is deployable as a web-based application or as a secure, on-premises solution within a sponsor’s cloud infrastructure [medium confidence] | https://www.unlearn.ai/digital-twins |
| Production site | Digital twin generation platforms deployed within sponsor-controlled secure cloud environments [medium confidence] | https://www.unlearn.ai/digital-twins |

Independent sources: businesswire.com, casrai.org, datanyze.com

## Technologies

- [Patient digital twins & in-silico trials](https://en.bioecon.ru/technology/patient-digital-twins-in-silico-trials/)